International
The Morning Science

What science found today

‹
 

Research

Viscoelasticity of synthetic antigen presenting cells reprograms T cell metabolism for TCR-T cell manufacturing and therapy

Nature · By Youcheng Yang ·

The Brief

  • Published online in Nature Communications on 20 November 2026 (doi:10.1038/s41467-026-78131-6).
  • Builds on earlier work by Li and colleagues on viscoelastic synthetic antigen-presenting cells for CAR-T therapy.
  • Reports that fast-relaxing synthetic antigen-presenting cells reprogram T cell metabolism, with relevance to TCR-T cell manufacturing and therapy.

Why it matters

It suggests that the mechanical properties of artificial cells used to activate T cells can change the T cells' metabolism, which could matter for how cell therapies are manufactured.

Who’s affected

  • immunologists and cell therapy researchers
  • biomedical engineers working on T cell manufacturing

Nature Communications, Published online: 20 November 2026; doi:10.1038/s41467-026-78131-6 Li and colleagues have previously reported the generation of viscoelastic synthetic antibody-presenting cells for CAR-T therapy. Here the authors report that fast-relaxing synthetic…

Timeline

  1. Published online in Nature Communications

  2. nature.com

    Viscoelasticity of synthetic antigen presenting cells reprograms T cell metabolism for TCR-T cell manufacturing and therapy

How do you feel about this?

0 Comments

    Viscoelasticity of synthetic antigen presenting cells reprograms T cell metabolism for TCR-T cell manufacturing and therapy – The Morning Science